NVUS
Novus Therapeutics Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Market Cap: 21 Million
Primary Exchange: NASDAQ CAPITAL MARKET
Website: http://novustherapeutics.com/
Shares Outstanding: 1.44 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.5378632744776484
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1717 trading days
From: 2014-09-17 To: 2021-01-04
Lowest Point:
Microcaps dominate midday movers
via: SeekingAlpha at 2019-06-12 08:39:07:000
Gainers: Synlogic (NASDAQ: SYBX ) +28% . Immuron (NASDAQ: IMRN ) +26% . B Communications (NASDAQ: BCOM ) +23% . Arcadia Biosciences (NASDAQ: RKDA ) +17% . Vuzix Corporation (NASDAQ: VUZI ) +14% . MagnaChip Semiconductor Corporation (NYSE: MX ) +13% . Osmotica Pharmaceuticals (N… read more...
Microcaps dominate midday movers
via: SeekingAlpha at 2019-06-12 08:39:07:000
Gainers: Synlogic (NASDAQ: SYBX ) +28% . Immuron (NASDAQ: IMRN ) +26% . B Communications (NASDAQ: BCOM ) +23% . Arcadia Biosciences (NASDAQ: RKDA ) +17% . Vuzix Corporation (NASDAQ: VUZI ) +14% . MagnaChip Semiconductor Corporation (NYSE: MX ) +13% . Osmotica Pharmaceuticals (N… read more...
Novus Therapeutics to Present OP0201 Data at the 20th International Symposium on Recent Advances in Otitis Media
via: Business Wire at 2019-06-10 04:30:00:000
Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that data from OP0201 study C-002 will be presented during the 20th International Symposium on Recent Adv… read more...
Novus Therapeutics to Present OP0201 Data at the 20th International Symposium on Recent Advances in Otitis Media
via: Business Wire at 2019-06-10 04:30:00:000
Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that data from OP0201 study C-002 will be presented during the 20th International Symposium on Recent Adv… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-05-11 | 9.0 | 1.0 | 9.0 |